Pilot Trial of the First Conversational Agent for Smoking Cessation (QuitBot)
NCT ID: NCT03585231
Last Updated: 2020-12-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
404 participants
INTERVENTIONAL
2018-09-17
2020-12-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental
This is the experimental arm of the study. This includes receiving immediate access to the novel/experimental smoking cessation messaging program. Therapy description withheld to protect the integrity of the study.
Immediate access to novel messaging program intervention
The experimental arm includes an immediate intervention using a novel messaging program for smoking cessation.
Control
This is the control arm of the study. This includes receiving receiving immediate access to the standard of care smoking cessation messaging program. Therapy description withheld to protect the integrity of the study.
Immediate access to standard of care messaging program intervention
The immediate control intervention uses a standard of care messaging program for smoking cessation.
Delayed Control
This is the second control arm of the study. This includes receiving the novel/experimental smoking cessation messaging program after completing the 3-month follow-up survey. Therapy description withheld to protect the integrity of the study.
Delayed access to novel novel messaging program intervention
The delayed control intervention uses the novel messaging program for smoking cessation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Immediate access to novel messaging program intervention
The experimental arm includes an immediate intervention using a novel messaging program for smoking cessation.
Immediate access to standard of care messaging program intervention
The immediate control intervention uses a standard of care messaging program for smoking cessation.
Delayed access to novel novel messaging program intervention
The delayed control intervention uses the novel messaging program for smoking cessation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* smokes at least five cigarettes daily for at least past 12 months
* wants to quit cigarette smoking in the next 14 days
* if concurrently using any other nicotine or tobacco products, wants to quit using them within the next 14days
* resides in western Washington State (in the following counties: Clallam, Grays Harbor, Island, Jefferson, King, Kitsap, Mason, Pierce, San Juan, Skagit, Snohomish, Thurston, and Whatcom)
* interested in learning skills to quit smoking
* willing to be randomly assigned to either condition
* has at least daily access to their own personal smartphone
* has and uses both text messaging and Facebook Messenger on their smartphone
* willing and able to read in English
* not using other smoking cessation interventions (including apps or our other intervention studies).
* willing to complete one 3-month follow-up survey
* willing to provide email, phone, and mailing address.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fred Hutchinson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jonathan Bricker, PhD
Role: PRINCIPAL_INVESTIGATOR
Fred Hutchinson Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bricker JB, Sullivan B, Mull K, Santiago-Torres M, Lavista Ferres JM. Conversational Chatbot for Cigarette Smoking Cessation: Results From the 11-Step User-Centered Design Development Process and Randomized Controlled Trial. JMIR Mhealth Uhealth. 2024 Jul 23;12:e57318. doi: 10.2196/57318.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2018-03684
Identifier Type: REGISTRY
Identifier Source: secondary_id
RG1001766
Identifier Type: OTHER
Identifier Source: secondary_id
8659
Identifier Type: OTHER
Identifier Source: secondary_id
8659
Identifier Type: -
Identifier Source: org_study_id